A carregar...
Tolerance and adverse event profile with sorafenib in Indian patients with advanced hepatocellular carcinoma
BACKGROUND: The current standard of treatment for advanced hepatocellular cancer Hepatocellular carcinoma (HCC) is Sorafenib. Data regarding its tolerance and adverse event profile in Indian patients is scarce. MATERIALS AND METHODS: The primary aim of this analysis was to assess the adverse events...
Na minha lista:
| Publicado no: | South Asian J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5763620/ https://ncbi.nlm.nih.gov/pubmed/29404288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_44_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|